New Product Planning

Core Responsibilities

• Co-develop Target Product Profiles (TPPs)
• Provide US commercial input to trial design/evidence generation, regulatory/labeling strategy, and differentiation vs. standard of care
• Translate scientific and clinical data into commercial implications, risks, and opportunities
• Support assets from preclinical through Phase II/III decision points
• Build deep understanding of disease biology/paradigm, patient segmentation/unmet need, and competitive pipeline
• Lead market-shaping strategies (disease awareness, diagnostic pathway evolution, KOL engagement, scientific leadership positioning, early value proposition/positioning)
• Generate insights through primary research, competitive intelligence, and analog analysis
• Anticipate future market dynamics and access environment (pricing, reimbursement, guidelines)
• Lead US commercial assessments (market sizing/epidemiology/patient flow, forecasting/valuation, scenario planning/risk)
• Support governance forums (portfolio prioritization, stage-gate decisions, BD/licensing evaluations)
• Recommend where to invest vs. deprioritize
• Drive cross-functional alignment (R&D, Medical, Market Access, Regulatory, Commercial)
• Build early brand strategy and launch blueprint (positioning, value story, evidence plan, go-to-market hypotheses)
• Define required future capabilities (field model, diagnostics, patient identification, payer engagement)
• Establish a 2–5 year pre-launch roadmap and milestones
• Serve as US commercial lead on global asset teams
• Influence senior stakeholders without direct authority
• Engage external stakeholders (KOLs, investigators, scientific societies)
• Operate as a matrix leader across geographies and functions

Qualifications

• Bachelor’s degree required
• MBA or advanced degree preferred (PharmD, MBA)
• 8–12+ years in pharma/biotech
• Experience in one or more: New Product Planning; Clinical Development; Oncology Marketing/Market Access; Medical Affairs
• Key Skills & Capabilities: Strategic thinking, ability to connect science → market → value; Oncology expertise: disease biology, clinical pathways, competitive landscape; Immunology Experience; Clinical-commercial integration; Fluency in both domains; Market shaping mindset (not just market entry); Advanced analytics: forecasting, valuation, scenario modeling; Influence without authority in complex matrix organizations; Strong communication: translating complex science into clear strategy